Legal Representation
Attorney
HAROLD J MILSTEIN
USPTO Deadlines
Application History
14 eventsDate | Code | Type | Description |
---|---|---|---|
Jan 31, 2005 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
Jan 31, 2005 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
Jun 25, 2004 | CFIT | O | CASE FILE IN TICRS |
Mar 30, 2004 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
Mar 8, 2004 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Feb 23, 2004 | I | PAPER RECEIVED | |
Sep 8, 2003 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED |
Aug 11, 2003 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Jul 29, 2003 | PUBO | A | PUBLISHED FOR OPPOSITION |
Jul 9, 2003 | NPUB | O | NOTICE OF PUBLICATION |
May 29, 2003 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
May 19, 2003 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Nov 18, 2002 | GNRT | F | NON-FINAL ACTION E-MAILED |
Nov 15, 2002 | DOCK | D | ASSIGNED TO EXAMINER |
Detailed Classifications
Class 005
Pharmaceutical compositions, namely, drugs for use in the treatment of cancer and psoriasis.
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
USPTO Documents
Loading USPTO documents...